BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 17689933)

  • 1. Bacteraemia in febrile neutropenic cancer patients.
    Klastersky J; Ameye L; Maertens J; Georgala A; Muanza F; Aoun M; Ferrant A; Rapoport B; Rolston K; Paesmans M
    Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S51-9. PubMed ID: 17689933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream infections in cancer patients with febrile neutropenia.
    Feld R
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S30-3. PubMed ID: 18778919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M; Thamlikitkul V
    J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for Gram-negative bacterial infections in febrile neutropenia.
    Cordonnier C; Herbrecht R; Buzyn A; Leverger G; Leclercq R; Nitenberg G; Bastuji-Garin S;
    Haematologica; 2005 Aug; 90(8):1102-9. PubMed ID: 16079110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
    Baskaran ND; Gan GG; Adeeba K
    Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients.
    Cairo J; Hachem R; Rangaraj G; Granwehr B; Raad I
    Clin Microbiol Infect; 2011 Nov; 17(11):1711-6. PubMed ID: 21595787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
    Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A;
    N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.
    Kern WV; Heiss M; Steinbach G
    Clin Infect Dis; 2001 Mar; 32(5):832-5. PubMed ID: 11229856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
    Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
    Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies.
    Malik I; Hussain M; Yousuf H
    J Infect; 2001 Feb; 42(2):120-5. PubMed ID: 11531318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanon: a view of the past decade.
    Kanafani ZA; Dakdouki GK; El-Chammas KI; Eid S; Araj GF; Kanj SS
    Int J Infect Dis; 2007 Sep; 11(5):450-3. PubMed ID: 17337226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
    Ramphal R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S25-31. PubMed ID: 15250017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
    Gudiol C; Tubau F; Calatayud L; Garcia-Vidal C; Cisnal M; Sánchez-Ortega I; Duarte R; Calvo M; Carratalà J
    J Antimicrob Chemother; 2011 Mar; 66(3):657-63. PubMed ID: 21193475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications.
    Engel A; Knoll S; Kern P; Kern WV
    Infection; 2005 Oct; 33(5-6):380-2. PubMed ID: 16258872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
    Todeschini G; Tecchio C; Borghero C; D'Emilio A; Pegoraro E; de Lalla F; Benedetti P; Spolaore P; Pellizzer G
    J Infect; 2006 Oct; 53(4):266-73. PubMed ID: 16388852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility.
    Sigurdardottir K; Digranes A; Harthug S; Nesthus I; Tangen JM; Dybdahl B; Meyer P; Hopen G; Løkeland T; Grøttum K; Vie W; Langeland N
    Scand J Infect Dis; 2005; 37(6-7):455-64. PubMed ID: 16012006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.
    D'Antonio D; Iacone A; Fioritoni G; Betti S; Dell'Isola M; Quaglietta AM; Accorsi P; Pantalone V; Recchia A; Piergallini A
    Drugs Exp Clin Res; 1992; 18(4):141-6. PubMed ID: 1451644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
    Delarive P; Baumgartner JD; Glauser MP; Cometta A
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.